MARKET

HROW

HROW

Harrow Health Inc
NASDAQ
33.85
+0.39
+1.17%
After Hours: 33.85 0 0.00% 16:20 01/17 EST
OPEN
33.76
PREV CLOSE
33.46
HIGH
34.45
LOW
33.04
VOLUME
277.67K
TURNOVER
--
52 WEEK HIGH
59.23
52 WEEK LOW
9.13
MARKET CAP
1.21B
P/E (TTM)
-35.9838
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at HROW last week (0113-0117)?
Weekly Report · 19h ago
Noteworthy Monday Option Activity: UAL, ENPH, HROW
NASDAQ · 01/13 20:19
Weekly Report: what happened at HROW last week (0106-0110)?
Weekly Report · 01/13 11:51
Harrow Health (HROW) Gets a Buy from Craig-Hallum
TipRanks · 01/07 14:06
Harrow names new chief scientific officer
Seeking Alpha · 01/07 13:51
Harrow announces Amir Shojaei, PharmD, PhD joins as CSO
TipRanks · 01/07 12:11
HARROW APPOINTS AMIR H. SHOJAEI AS CHIEF SCIENTIFIC OFFICER
Reuters · 01/07 12:00
Weekly Report: what happened at HROW last week (1230-0103)?
Weekly Report · 01/06 12:01
More
About HROW
Harrow, Inc. is an eyecare pharmaceutical company. The Company is engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the United States market. It provides a comprehensive portfolio of prescription and non-prescription pharmaceutical products. It owns commercial rights to portfolios of branded ophthalmic pharmaceutical products in North America, all of which are marketed under the Harrow name. It owns and operates ImprimisRx, an ophthalmology-focused pharmaceutical-compounding business. It owns United States commercial rights to various products: IHEEZO, VEVYE, TRIESENCE, VIGAMOX, ILEVRO, FLAREX, NATACYN, ZERVIATE and others. VIGAMOX (moxifloxacin hydrochloride ophthalmic solution) 0.5%, a fluoroquinolone antibiotic eye drops for the treatment of bacterial conjunctivitis caused by susceptible strains of organisms. IHEEZO (chloroprocaine hydrochloride ophthalmic gel) 3% is a low-viscosity gel indicated for ocular surface anesthesia.

Webull offers Harrow Inc stock information, including NASDAQ: HROW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HROW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HROW stock methods without spending real money on the virtual paper trading platform.